Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Factor VIIa-CTP
print preview
bookmark
share with colleague
General Information
Company
Prolor Biotech Inc.
Description
Long-acting formulation of recombinant Factor VIIa complex developed using carboxyl terminal peptide (CTP) technology
Molecular Target
Factor VIIa
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Hemophilia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information